Today, the Trump Administration is pleased to announce the purchase and production of 150 million rapid tests to be distributed across the country. In March, President Donald J. Trump called for the development of a low cost, reliable point-of-care test. To deliver on this promise, the Administration has partnered with Abbott Laboratories to produce inexpensive and easy-to-use Abbott BinaxNOW tests. This is a major development that will help save more lives by further protecting America’s most vulnerable and allow our country to remain open, get Americans back to work, and get kids back to school. Under President Trump’s leadership, the...